Ingram, J. R., M. Porter, R. Chovatiya, E. J. Giamarellos-Bourboulis, F. G. Bechara, H. Fujita, W. Gulliver, E. Muller, M. Bari, R. Rolleri, R. Byerly, and J. S. Kirby. “Bimekizumab Response Maintenance to 48 Weeks in Patients With Moderate to Severe Hidradenitis Suppurativa: Pooled Responder Analysis from the Phase 3, Double-Blind, Placebo-Controlled, Randomized Clinical Trials BE HEARD I and II”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s396, doi:10.25251/skin.8.supp.396.